-
1دورية أكاديمية
المؤلفون: ARTAÇ, MEHMET, GÜRBÜZ, MUSTAFA, Kilickap, Saadettin, BİLİCİ, Ahmet, Karadurmus, Nuri, Sezer, Ahmet, ŞENDUR, MEHMET ALİ NAHİT, PAYDAŞ, SEMRA, Fulden Yumuk, Perran, GÜRSOY, PINAR, Uysal, Mukremin, Senol Coskun, Hasan, TATLI, ALİ MURAT, Selcukbiricik, Fatih, Disel, Umut, KÖKSOY, ELİF BERNA, GÜVEN, DENİZ CAN, Ugrakli, Muzaffer, AKKUŞ, ERMAN, YÜCEL, ŞEBNEM, EROL, CİHAN, Karakaya, Serdar, Sakalar, Teoman, Khanmammadov, Nijat, Paksoy, Nail, DEMİRKAZIK, AHMET
المساهمون: Ankara Üniversitesi ,, 4310561
مصطلحات موضوعية: Genel Sağlık Meslekleri, TIP, GENEL & DAHİLİ, Klinik Tıp, Klinik Tıp (MED), Tıp, Sağlık Bilimleri, Temel Tıp Bilimleri, Patofizyoloji, Temel Bilgi ve Beceriler, Değerlendirme ve Teşhis, Dahiliye, Aile Sağlığı, Tıp (çeşitli), Genel Tıp
العلاقة: MEDICINE; GÜRBÜZ M., Kilickap S., BİLİCİ A., Karadurmus N., Sezer A., ŞENDUR M. A. N., PAYDAŞ S., ARTAÇ M., Fulden Yumuk P., GÜRSOY P., et al., "Crizotinib efficacy and safety in patients with advanced NSCLC harboring MET alterations: A real-life data of Turkish Oncology Group", MEDICINE, cilt.101, sa.50, 2022; vv_1032021; av_1ac149d4-413f-43e4-949c-8f82f0b9189f; http://hdl.handle.net/20.500.12627/189928Test; https://doi.org/10.1097/md.0000000000032368Test; 101; 50
الإتاحة: https://doi.org/20.500.12627/189928Test
https://doi.org/10.1097/md.0000000000032368Test
https://hdl.handle.net/20.500.12627/189928Test -
2دورية أكاديمية
المؤلفون: Ozdemir, Ozlem, Karakas, Yusuf, Alkan, Ali, Yasar, Arzu, Guc, Zeynep Gulsum, Gurbuz, Mustafa, BAŞOĞLU TÜYLÜ, TUĞBA, SEZGİN GÖKSU, SEMA, Basal, Fatma Bugdayci, TÜRK, HACI MEHMET, Cinkir, Havva Yesil, Guven, Deniz Can, Kus, Tulay, Turker, Sema, KORAL, LOKMAN, PAYDAŞ, SEMRA, Karci, Ebru, Demiray, Atike Gokcen, Demir, Atakan, Alan, Ozkan, KESKİN, ÖZGE, Nayir, Erdinc, TANRIVERDİ, ÖZGÜR, YAVUZŞEN, TUĞBA, Yumuk, Perran Fulden, Ates, Ozturk, COŞKUN, HASAN ŞENOL, Turhal, Serdar, ŞENLER, FİLİZ ÇAY, Ak, Naziye
المساهمون: Acibadem Hospitals Group ,, 2285836
-
3دورية أكاديمية
المؤلفون: Turkoz, Fatma Paksoy, Olmez, Omer Fatih, ERMAN, MUSTAFA, COŞKUN, HASAN ŞENOL, Selcukbiricik, Fatih, KESKİN, ÖZGE, Tural, Deniz, ORUÇ, Kerem, Bayram, Selami, Bilgetekin, Irem, Yildiz, Birol, Sendur, Mehmet Ali Nahit, Paksoy, Nail, Dirican, Ahmet, Erdem, Dilek, Selam, Meltem, TANRIVERDİ, ÖZGÜR, PAYDAŞ, SEMRA, Urakci, Zuhat, Atag, Elif, Guncan, Sabri, ÜRÜN, YÜKSEL, Alkan, Ali, Kaya, Ali Osman, Ozyukseler, Deniz Tataroglu, Taskaynatan, Halil, Yildirim, Mustafa, Sonmez, Muge, BAŞOĞLU TÜYLÜ, TUĞBA, Gunduz, Seyda, Kilickap, Saadettin, ARTAÇ, MEHMET, Sumbul, Ahmet Taner, Ozhan, Nail, ÇAKAR, BURCU, Kostek, Osman, Ekenel, Meltem
المساهمون: İstanbul Üniversitesi ,, 2636235
مصطلحات موضوعية: ONKOLOJİ, Klinik Tıp (MED), Tıp, Sağlık Bilimleri, Dahili Tıp Bilimleri, İç Hastalıkları, Onkoloji, Oncology, Health Sciences, Klinik Tıp
العلاقة: INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY; Tural D., Olmez O. F. , Sumbul A. T. , Ozhan N., ÇAKAR B., Kostek O., Ekenel M., ERMAN M., COŞKUN H. Ş. , Selcukbiricik F., et al., "Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab", INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, cilt.26, ss.1506-1513, 2021; av_8d62a86a-0e4f-4339-9426-b0070cd55957; vv_1032021; http://hdl.handle.net/20.500.12627/172390Test; https://doi.org/10.1007/s10147-021-01936-6Test; 26; 1506; 1513
الإتاحة: https://doi.org/20.500.12627/172390Test
https://doi.org/10.1007/s10147-021-01936-6Test
https://hdl.handle.net/20.500.12627/172390Test -
4دورية أكاديمية
المؤلفون: Gullo, Giuseppe, Gao, Bo, Li, Siyu, Lee, Sue, McGuire, Kristina, Chen, Chieh-, Makharadze, Tamta, PAYDAŞ, SEMRA, Nechaeva, Marina, Seebach, Frank, Weinreich, David M., Yancopoulos, George D., Lowy, Israel, Rietschel, Petra, Sezer, Ahmet, KILIÇKAP, SAADETTİN, GÜMÜŞ, MAHMUT, Bondarenko, Igor, ÖZGÜROĞLU, Mustafa, Gogishvili, Miranda, TÜRK, HACI MEHMET, ÇİÇİN, İRFAN, Bentsion, Dmitry, Gladkov, Oleg, Clingan, Philip, Sriuranpong, Virote, Rizvi, Naiyer
المساهمون: Başkent Üniversitesi ,, 2533397
مصطلحات موضوعية: Fundamentals and Skills, Pathophysiology, Internal Medicine, Assessment and Diagnosis, Medicine (miscellaneous), General Medicine, Health Sciences, TIP, GENEL & İÇECEK, Klinik Tıp, Klinik Tıp (MED), Tıp, Sağlık Bilimleri, Temel Tıp Bilimleri, Family Practice, General Health Professions
العلاقة: LANCET; Sezer A., KILIÇKAP S., GÜMÜŞ M., Bondarenko I., ÖZGÜROĞLU M., Gogishvili M., TÜRK H. M. , ÇİÇİN İ., Bentsion D., Gladkov O., et al., "Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial", LANCET, cilt.397, sa.10274, ss.592-604, 2021; vv_1032021; av_6ae74563-f114-481e-a051-e418bc5ab7e6; http://hdl.handle.net/20.500.12627/171314Test; https://doi.org/10.1016/s0140-6736Test(21)00228-2; 397; 10274; 592; 604
الإتاحة: https://doi.org/20.500.12627/171314Test
https://doi.org/10.1016/s0140-6736Test(21)00228-2
https://hdl.handle.net/20.500.12627/171314Test -
5دورية أكاديمية
المؤلفون: Gulmez, Ahmet, AKTAŞ, BURAK YASİN, BAŞOĞLU TÜYLÜ, TUĞBA, Ilhan, Aysegul, Akdeniz, Nadiye, Dogan, Izzet, Kilickap, Sadettin, Karaagac, Mustafa, Avci, Okan, Sen, Erdem, Bilgin, Burak, Sendur, Mehmet Ali Nahit, Yucel, Sebnem, Yalcin, Bulent, Oksuzoglu, Berna, DEMİRKAZIK, AHMET, Demir, Atakan, Dede, Didem Sener, Akinci, Muhammed Bulent, KARATAŞ, FATİH, Deniz, Gulhan Ipek, Taskaynatan, Halil, Sakalar, Teoman, Menevse, Serkan, Kut, Engin, Hizal, Mutlu, Erol, Cihan, Alan, Ozkan, Cinkir, Havva Yesil, TATLI, ALİ MURAT, PAYDAŞ, SEMRA, Yumuk, Fulden, KOCA, SİNAN, Gurbuz, Mustafa, Celik, Emir, Ozyukseler, Deniz Tataroglu, Ayhan, Murat
المساهمون: Necmeddin Erbakan Univ ,, 2513623
مصطلحات موضوعية: Klinik Tıp, Health Sciences, Oncology, Onkoloji, İç Hastalıkları, Dahili Tıp Bilimleri, Sağlık Bilimleri, Klinik Tıp (MED), Tıp, ONKOLOJİ
العلاقة: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY; Bilgin B., Sendur M. A. N. , Yucel S., Celik E., Ozyukseler D. T. , Ayhan M., BAŞOĞLU TÜYLÜ T., Ilhan A., Akdeniz N., Gulmez A., et al., "Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study", JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021; vv_1032021; av_b69c7d9b-0c65-486a-bb32-b6c885e97255; http://hdl.handle.net/20.500.12627/1636Test; https://doi.org/10.1007/s00432-020-03501-6Test
الإتاحة: https://doi.org/20.500.12627/1636Test
https://doi.org/10.1007/s00432-020-03501-6Test
https://hdl.handle.net/20.500.12627/1636Test -
6دورية أكاديمية
المؤلفون: GÖKMEN, ERHAN, TEKİN, Salim Başol, Calikusu, Zuleyha, Yavuz, Sinan, ŞAHİN, AHMET BİLGEHAN, ÇUBUKÇU, ERDEM, EVRENSEL, TÜRKKAN, Degirmencioglu, Serkan, Demiray, Atike Gokcen, YUMUK, PERRAN FULDEN, Alan, Ozkan, Cikman, Duygu Ilke, Demirelli, Fuat Hulusi, Kostek, Osman, Gokyer, Ali, Dogan, Mutlu, Bal, Oznur, ÇAKAR, BURCU, ŞİMŞEK, Melih, Yamac, Deniz, Korkmaz, Taner, Aliyev, Altay, KESKİN, ÖZGE, Urvay, Semiha, BÜYÜKŞİMŞEK, MAHMUT, Karadeniz, Cemile, Yildiz, Birol, Cinkir, Havva Yesil, Demir, Hacer, Beypinar, Ismail, Karacin, Cengiz, Eser, Kadir, Baykara, Meltem, KILIÇKAP, SAADETTİN, Okutur, Kerem, Bulut, Gulcan, Alkan, Ali, Bahceci, Aykut, PAYDAŞ, SEMRA, Ak, Naziye, Ferhatoglu, Ferhat, Saip, Pinar Mualla, SEYDAOĞLU, GÜLŞAH, BİLİCİ, Mehmet, Arpaci, Erkan, Pilanci, Kezban Nur, Demir, Atakan, Isik, Deniz, Yildirim, Nilgun
المساهمون: Dr. Ersin Arslan Education & Research Hospital ,, 2646052
مصطلحات موضوعية: Onkoloji, Oncology, Health Sciences, Tıp, Klinik Tıp (MED), Klinik Tıp, ONKOLOJİ, Dahili Tıp Bilimleri, İç Hastalıkları, Sağlık Bilimleri
العلاقة: CANCER INVESTIGATION; Bahceci A., PAYDAŞ S., Ak N., Ferhatoglu F., Saip P. M. , SEYDAOĞLU G., BİLİCİ M., ŞİMŞEK M., TEKİN S. B. , Calikusu Z., et al., "Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience", CANCER INVESTIGATION, 2021; av_aac8c4f6-ce5e-44fd-87c4-875edd940669; vv_1032021; http://hdl.handle.net/20.500.12627/173315Test; https://doi.org/10.1080/07357907.2021.1933011Test
الإتاحة: https://doi.org/20.500.12627/173315Test
https://doi.org/10.1080/07357907.2021.1933011Test
https://hdl.handle.net/20.500.12627/173315Test -
7دورية أكاديمية
المؤلفون: EROL, CİHAN, Gurbuz, Mustafa, Ak, Naziye, Yucel, Sebnem, Ayhan, Murat, Demirkiran, Aykut, Mandel, Nil Molinas, Gokmen, Ivo, Shbair, Abdallah, BAŞOĞLU TÜYLÜ, TUĞBA, PAYDAŞ, SEMRA, Demiray, Atike Gokcen, Iriagac, Yakup, Sakalar, Teoman, Zeynelgil, Esra, TATLI, ALİ MURAT, Bahceci, Aykut, Guven, Deniz Can, Caner, Burcu, Can, Alper, Gulmez, Ahmet, Karakas, Yusuf, YALÇIN, BÜLENT, DEMİRKAZIK, AHMET, Bilici, Ahmet, Aydiner, Adnan, YUMUK, PERRAN FULDEN, ŞENDUR, MEHMET ALİ NAHİT, Hizal, Mutlu, Bilgin, Burak, Paksoy, Nail, Acikgoz, Ozgur, Sezer, Ahmet
المساهمون: Ankara City Hosp ,, 2703289
مصطلحات موضوعية: Health Sciences, Sağlık Bilimleri, Dahili Tıp Bilimleri, İç Hastalıkları, Onkoloji, Oncology, ONKOLOJİ, Klinik Tıp, Klinik Tıp (MED), Tıp
العلاقة: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY; Hizal M., Bilgin B., Paksoy N., Acikgoz O., Sezer A., Gurbuz M., Ak N., Yucel S., Ayhan M., EROL C., et al., "The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study", JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021; vv_1032021; av_ffd69354-68f8-4566-8d23-aeea4c28d53f; http://hdl.handle.net/20.500.12627/175958Test; https://doi.org/10.1007/s00432-021-03748-7Test
الإتاحة: https://doi.org/20.500.12627/175958Test
https://doi.org/10.1007/s00432-021-03748-7Test
https://hdl.handle.net/20.500.12627/175958Test -
8دورية أكاديمية
المؤلفون: Tural, Deniz, Gautschi, Oliver, Zirtiloglu, Alisan, Eralp, Yesim, Cinkir, Havva Yesil, Sezer, Ahmet, ERMAN, MUSTAFA, Turna, Hande, Yumuk, Perran Fulden, Yildiz, Ibrahim, Kaplan, M. Ali, ÖZYILKAN, ÖZGÜR, Oztop, Ilhan, Olmez, Omer Fatih, Aydin, Kubra, Aydiner, Adnan, Meydan, Nezih, Grinberg, Roxana Denisa, Roisman, Laila C., ÇABUK, DEVRİM, Isikdogan, Abdurrahman, Sendur, Mehmet Ali Nahit, Coskun, Hasan Senol, Okutur, Kerem, Karaoglu, Aziz, Demirkazik, Ahmet, Yazilitas, Dogan, Beypinar, Ismail, Senler, Filiz Cay, Ng, Terry L., Camidge, David Ross, Dudnik, Elizabeth, Reguart, Noemi, Mazieres, Julien, Peled, Nir, Gillis, Roni, KILIÇKAP, SAADETTİN, Froesch, Patrizia, Orlov, Sergei, Filippova, Elena, Demirci, Umut, Christopoulos, Petros, ÇİÇİN, İRFAN, Basal, Fatma Bugdayci, Yilmaz, Cengiz, Fedor, Moiseenko, Korkmaz, Taner, Paydas, Semra
المساهمون: Rabin Medical Center ,, 2288122
مصطلحات موضوعية: Dahili Tıp Bilimleri, Sağlık Bilimleri, Tıp, SOLUNUM SİSTEMİ, Onkoloji, İç Hastalıkları, Göğüs Hastalıkları ve Allerji, Klinik Tıp (MED), Klinik Tıp, ONKOLOJİ
العلاقة: LUNG CANCER; Peled N., Gillis R., KILIÇKAP S., Froesch P., Orlov S., Filippova E., Demirci U., Christopoulos P., ÇİÇİN İ., Basal F. B. , et al., "GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patients", LUNG CANCER, cilt.148, ss.48-54, 2020; vv_1032021; av_1467efc6-fcdf-43c6-a061-5b18428ff9fd; http://hdl.handle.net/20.500.12627/19120Test; https://doi.org/10.1016/j.lungcan.2020.07.022Test; 148; 48; 54
الإتاحة: https://doi.org/20.500.12627/19120Test
https://doi.org/10.1016/j.lungcan.2020.07.022Test
https://hdl.handle.net/20.500.12627/19120Test -
9دورية أكاديمية
المؤلفون: Ozdemir, Ozlem, Karakas, Yusuf, Alkan, Ali, Yasar, Arzu, Guc, Zeynep Gulsum, Gurbuz, Mustafa, BAŞOĞLU TÜYLÜ, TUĞBA, SEZGİN GÖKSU, SEMA, Basal, Fatma Bugdayci, TÜRK, HACI MEHMET, Cinkir, Havva Yesil, Guven, Deniz Can, Kus, Tulay, Turker, Sema, KORAL, LOKMAN, PAYDAŞ, SEMRA, Karci, Ebru, Demiray, Atike Gokcen, Demir, Atakan, Alan, Ozkan, KESKİN, ÖZGE, Nayir, Erdinc, TANRIVERDİ, ÖZGÜR, YAVUZŞEN, TUĞBA, Yumuk, Perran Fulden, Ates, Ozturk, COŞKUN, HASAN ŞENOL, Turhal, Serdar, ŞENLER, FİLİZ ÇAY, Ak, Naziye
المساهمون: Acibadem Hospitals Group ,, 2285836
مصطلحات موضوعية: SAĞLIK BAKIM BİLİMLERİ VE HİZMETLERİ, HEMŞİRELİK, REHABİLİTASYON, Tıp, Sağlık Bilimleri, Dahili Tıp Bilimleri, Aile Hekimliği, ONKOLOJİ, İç Hastalıkları, Onkoloji, Hemşirelik, Fiziksel Tıp ve Rehabilitasyon, Klinik Tıp, Klinik Tıp (MED)
العلاقة: EUROPEAN JOURNAL OF CANCER CARE; Alkan A., Yasar A., Guc Z. G. , Gurbuz M., BAŞOĞLU TÜYLÜ T., SEZGİN GÖKSU S., Basal F. B. , TÜRK H. M. , Ozdemir O., Cinkir H. Y. , et al., "Worse patient-physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG)", EUROPEAN JOURNAL OF CANCER CARE, 2020; vv_1032021; av_336ebf03-e868-4963-8d5d-7d58a87c584c; http://hdl.handle.net/20.500.12627/3936Test; https://doi.org/10.1111/ecc.13296Test
الإتاحة: https://doi.org/20.500.12627/3936Test
https://doi.org/10.1111/ecc.13296Test
https://hdl.handle.net/20.500.12627/3936Test -
10دورية أكاديمية
المؤلفون: ÖZCAN, MUHİT, Ferhanoglu, Burhan, TOPÇUOĞLU, PERVİN, Birtas, Elif, GÖKER, HAKAN, Ozbalak, Murat, SALİHOĞLU, Ayşe, Soysal, Teoman, Karadogan, Ihsan, PAYDAŞ, SEMRA, Ozdemir, Evren, Yildiz, Birol, Karadurmus, Nuri, KAYNAR, LEYLAGÜL, Yagci, Munci, ÖZKOCAMAN, VİLDAN
المساهمون: İstanbul Teknik Üniversitesi ,, 2277565
مصطلحات موضوعية: Sağlık Bilimleri, İç Hastalıkları, Hematoloji, Dahili Tıp Bilimleri, Tıp, Klinik Tıp (MED), Klinik Tıp, HEMATOLOJİ
العلاقة: ANNALS OF HEMATOLOGY; Ozbalak M., SALİHOĞLU A., Soysal T., Karadogan I., PAYDAŞ S., Ozdemir E., Yildiz B., Karadurmus N., KAYNAR L., Yagci M., et al., "Long-term results of brentuximab vedotin in relapsed and refractory Hodgkin lymphoma: multi-center real-life experience", ANNALS OF HEMATOLOGY, cilt.99, ss.301-307, 2020; vv_1032021; av_f3632a2f-42dd-4a8f-87d2-6b8e4db55413; http://hdl.handle.net/20.500.12627/159618Test; https://doi.org/10.1007/s00277-019-03899-1Test; 99; 301; 307
الإتاحة: https://doi.org/20.500.12627/159618Test
https://doi.org/10.1007/s00277-019-03899-1Test
https://hdl.handle.net/20.500.12627/159618Test
النص الكامل